JP2019521178A5 - - Google Patents

Download PDF

Info

Publication number
JP2019521178A5
JP2019521178A5 JP2019515760A JP2019515760A JP2019521178A5 JP 2019521178 A5 JP2019521178 A5 JP 2019521178A5 JP 2019515760 A JP2019515760 A JP 2019515760A JP 2019515760 A JP2019515760 A JP 2019515760A JP 2019521178 A5 JP2019521178 A5 JP 2019521178A5
Authority
JP
Japan
Prior art keywords
amoxicillin
formulation
powder
cineole
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019515760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019521178A (ja
JP7033586B2 (ja
Filing date
Publication date
Priority claimed from MA39084A external-priority patent/MA39084A1/fr
Priority claimed from FR1655018A external-priority patent/FR3052065B1/fr
Priority claimed from MA39085A external-priority patent/MA39085B1/fr
Priority claimed from FR1655017A external-priority patent/FR3052066B1/fr
Application filed filed Critical
Priority claimed from PCT/MA2017/000014 external-priority patent/WO2017209588A2/fr
Publication of JP2019521178A publication Critical patent/JP2019521178A/ja
Publication of JP2019521178A5 publication Critical patent/JP2019521178A5/ja
Application granted granted Critical
Publication of JP7033586B2 publication Critical patent/JP7033586B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019515760A 2016-06-02 2017-06-02 シネオールとアモキシシリンとを含む医薬製剤 Active JP7033586B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
FR1655018 2016-06-02
FR1655017 2016-06-02
MA39085 2016-06-02
MA39084A MA39084A1 (fr) 2016-06-02 2016-06-02 Formulation pharmaceutique de cineol et d'amoxicilline
FR1655018A FR3052065B1 (fr) 2016-06-02 2016-06-02 Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne
MA39084 2016-06-02
MA39085A MA39085B1 (fr) 2016-06-02 2016-06-02 Combinaison de cineol et d'amoxicilline pour une utilisation dans le traitement d'une infection bacterienne
FR1655017A FR3052066B1 (fr) 2016-06-02 2016-06-02 Formulation pharmaceutique de cineol et d'amoxicilline
PCT/MA2017/000014 WO2017209588A2 (fr) 2016-06-02 2017-06-02 Formulation pharmaceutique de cinéol et d'amoxicilline

Publications (3)

Publication Number Publication Date
JP2019521178A JP2019521178A (ja) 2019-07-25
JP2019521178A5 true JP2019521178A5 (enExample) 2020-06-25
JP7033586B2 JP7033586B2 (ja) 2022-03-10

Family

ID=59399462

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019515760A Active JP7033586B2 (ja) 2016-06-02 2017-06-02 シネオールとアモキシシリンとを含む医薬製剤

Country Status (8)

Country Link
US (2) US11872216B2 (enExample)
EP (1) EP3463479B1 (enExample)
JP (1) JP7033586B2 (enExample)
CN (1) CN109562182A (enExample)
CA (1) CA3026323A1 (enExample)
MA (1) MA44286A (enExample)
SA (1) SA518400554B1 (enExample)
WO (1) WO2017209588A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109562182A (zh) * 2016-06-02 2019-04-02 先进科学发展公司 包含桉树脑和阿莫西林的药物制剂
US12460153B2 (en) 2019-12-04 2025-11-04 Pranarom International S.A. Method for transforming an essential oil
DE202021106639U1 (de) 2021-10-08 2023-01-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung Neue Therapiekonzepte für die Behandlung von Otitis
CN118267361B (zh) * 2024-05-31 2024-08-23 潍坊格润药业有限公司 一种兽用复方阿莫西林可溶性粉

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0412675A (pt) * 2003-07-17 2006-10-03 Univ Columbia composições antimicrobianas contendo combinações sinergìsticas de compostos de amÈnio quaternário e óleos essenciais e/ou constituintes
WO2006120495A1 (fr) 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
WO2006120494A1 (fr) 2005-05-13 2006-11-16 Advanced Scientific Developements Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol
WO2006120496A1 (fr) 2005-05-13 2006-11-16 Advanced Scientific Developements Combinaison pharmaceutique comprenant un agent antifongique et un actif choisi parmi le carveol, l’ eugenol, le thymol, le borneol, et le carvacrol
US20080139526A1 (en) * 2006-12-06 2008-06-12 Donald Treacy Modified release dosage forms of amoxicillin
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
JP2011516527A (ja) * 2008-04-09 2011-05-26 レツク・フアーマシユーテイカルズ・デー・デー 医薬品有効成分の造粒
FR2937549B1 (fr) 2008-10-29 2011-04-01 Centre Nat Rech Scient Nanoparticules de derives beta-lactamine
BR112013014189A8 (pt) * 2010-12-09 2018-01-09 Septeos composição farmacêutica, uso de um agente de potencialização e uso de uma composição
CA2827239A1 (en) 2011-02-25 2012-08-30 Universite D'angers Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic
NZ707855A (en) 2012-11-06 2018-11-30 Rochal Ind Llc Delivery of biologically-active agents using volatile, hydrophobic solvents
MA35295B1 (fr) 2012-12-31 2014-08-01 Advanced Scient Developments Complexe moleculaire detoxifiant et antimicrobien
FR3025719A1 (fr) * 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
CN109562182A (zh) * 2016-06-02 2019-04-02 先进科学发展公司 包含桉树脑和阿莫西林的药物制剂

Similar Documents

Publication Publication Date Title
KR100495585B1 (ko) 제약 제제
JPH02209809A (ja) 抗菌剤
JP2013532729A5 (enExample)
JP2011506587A5 (enExample)
CN1198611C (zh) 药物抗菌剂组合物
JPH0692850A (ja) 胃腸障害治療薬
CN1336827A (zh) 口服药物组合物
KR20080109020A (ko) 오셀타미버 포스페이트 과립 및 그의 제조방법
CN102697736A (zh) 一种头孢克肟颗粒及其制备方法
BRPI0612447A2 (pt) composição antibiótica de dose fixa, processo para a preparação de um produto de combinação antibiótica de dose fixa, processo para a preparação de uma injeção lìquida e usos de pó seco para injeção e injeção lìquida
JP2019521178A (ja) シネオールとアモキシシリンとを含む医薬製剤
JPS5982311A (ja) セフアレキシン持効性製剤
CN102018953A (zh) 含诺卡沙星抗生素的药物组合物
CN108670956A (zh) 一种阿莫西林可溶性粉及其制备方法
JP2011502103A (ja) カルバペネム類を含む殺菌性抗mrsa活性医薬組成物
JPH01268637A (ja) 経口投与用抗菌組成物
ES2316957T3 (es) Composicion medicinal para tratar la infeccion con staphylococcus aureus resistente a farmacos.
HU222888B1 (hu) Anilid vegyületek alkalmazása I típusú allergiás betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
CN100553635C (zh) 含有阿莫西林、氨溴索和β内酰胺酶抑制剂的药物组合物及其应用
EP3643325A1 (en) A composition comprising furazidin and a method of its manufacturing
JP2006522089A (ja) 被覆オキサゾリジノン粒子のための味のマスキング用ビヒクル
KR100990223B1 (ko) 세프디니르의 용출속도를 개선한 약제학적 조성물
CN103845284A (zh) 一种硫酸新霉素溶液剂及其制备方法
JP2008517977A5 (enExample)
EP1860944A2 (en) Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections